What is Bioventus's operating cash flow?

Bioventus (BVS) reported operating cash flow of $8.93M in Q1 2026.

How has Bioventus's operating cash flow changed year-over-year?

Bioventus's operating cash flow increased by 146.2% year-over-year, from -$19.33M to $8.93M.

What is the long-term trend for Bioventus's operating cash flow?

Over 2 years (2021 to 2025), Bioventus's operating cash flow has grown at a 80.2% compound annual growth rate (CAGR), from $22.99M to $74.67M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Bioventus BVS Operating Cash Flow

Operating Cash Flow at other companies

StrykerSYK

$581M+132%

Zimmer Biomet HoldingsZBH

$359.4M-6.1%

MedtronicMDT

$2.57B+1.8%

SI-BONE, Inc.SIBN

-$2.36M+51.9%

ArtivionAORT

$1.15M+107%

Globus MedicalGMED

$202.36M+14.1%

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's operating cash flow?: Bioventus (BVS) reported operating cash flow of $8.93M in Q1 2026.
How has Bioventus's operating cash flow changed year-over-year?: Bioventus's operating cash flow increased by 146.2% year-over-year, from -$19.33M to $8.93M.
What is the long-term trend for Bioventus's operating cash flow?: Over 2 years (2021 to 2025), Bioventus's operating cash flow has grown at a 80.2% compound annual growth rate (CAGR), from $22.99M to $74.67M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.